Why the splash? Inari's game-changing clot-removal devices for deep vein thrombosis (DVT) and pulmonary embolism (PE) are a perfect fit for Stryker's neurovascular empire. This move doesn't just pad ...

It might be a long shot, but Ghost of Yotei could show an entirely different side of one of Ghost of Tsushima's most iconic ...

Jim Cramer, the host of Mad Money, recently highlighted a surge in merger activity, pointing out that we’ve seen a ...

The world is brimming with new adventures, and the good news is that there are many destinations globally where Americans can ...

A tier list and a reroll guide for this phenomenal visual novel, featuring a massive pool of characters and a gripping story to tell.

From seasonal blooms to healing hot spring waters and more, here are our top picks for 2025.

Craft your Japan itinerary with our comprehensive comparison between the bustling energy of Tokyo vs the timeless charm of ...

We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Inari Medical (NASDAQ:NARI) quickly jumped 31% after a report that Stryker (SYK) is in advanced discussions to purchase the company that makes devices for treating patients with venous diseases. A ...